Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study
Status:
Withdrawn
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study looks to continue the study of anti-vegf therapy in patients with macular edema,
and compare it to an anti-inflammatory therapy and a combined Anti-vegf and
anti-inflammatory.
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
Genentech, Inc. Juvenile Diabetes Research Foundation